Broadening access to cladribine should help more patients avoid hospital and free up clinic time.
You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...
A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...
While there is no cure for MS, there are many medications that can modify the course of the disease and improve symptoms. "Scientists have made significant advancements over the past decade that ...
Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Europe.
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
came under fire for delaying its decision on whether the breakthrough drug beta interferon should be available to all MS sufferers on the NHS. Catherine, who had to fight for her right to have the ...
In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...
A new study suggests that a simple treatment algorithm could significantly reduce disparities in multiple sclerosis care ...
The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results